These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Multiple sclerosis: clinical characteristics and disability progression in Moroccan children.
    Author: Ait Ben Haddou E, Alhyan M, Aasfara J, Regragui W, Ibrahimi A, Razine R, Abouqal R, Benomar A, Yahyaoui M.
    Journal: J Neurol Sci; 2014 Nov 15; 346(1-2):128-32. PubMed ID: 25216553.
    Abstract:
    BACKGROUND: 5% of multiple sclerosis have their onset in childhood. OBJECTIVES: We aim to show the clinical features and follow-up of Moroccan pediatric MS patients. METHODS: 25 pediatric MS records were analyzed between 2005 and 2013 at the Neurology B department of Rabat Ibn sina University Hospital and Medical School Group of Neurogenetic Disorder of Rabat Mohammed V University Souissi. RESULTS: The median duration of follow up was 4 years [1.56]. The median age at disease onset was 14 years. Clinical symptoms were described. At the last evaluation, the median EDSS score was 3.0 [0-7.5]. The median time between disease onset and diagnosis was 2 years [1-9] and the median time from MS onset to second neurological episode was 1 year [0.9-3] with an average of 2 relapses in the first 2 years. The median time to reach EDSS 3.0 was 4.5 years [2-17] and the median time to go from EDSS 3.0 to 6.0 was 4 years [2.5-6]. The majority of cases at the last follow-up were; relapsing-remitting (17 patients: 68%), although 8 patients (32%) developed secondary progressive MS after median disease duration of 5 years [4-19]. None of the patients had a primary progressive MS. CONCLUSION: Time EDSS 3.0 and to secondary progression was shorter in our cohort than previously reported in other series.
    [Abstract] [Full Text] [Related] [New Search]